Skip to main content
SpringerLink
Log in

Abatacept

Lack of efficacy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Boccieri E, et al. Use of abatacept as GVHD prophylaxis in pediatric patients undergoing HSCT from matched or mismatched unrelated donor. Bone Marrow Transplantation 57 (Suppl. 1): 230, Nov 2022. Available from: URL: http://doi.org/10.1038/s41409-022-01798-0 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abatacept. Reactions Weekly 1937, 15 (2022). https://doi.org/10.1007/s40278-022-29695-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29695-0

Search

Navigation